Hyperinflammation may also contribute to added healthcare costs, such as prolonged ICU stays and increased reliance on dialysis and mechanical ventilation ... The SCD-ADULT device has received FDA ...

SeaStar Medical’s SCD previously received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation ... increased reliance on dialysis and mechanical ventilation. The Selective ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration. A device that beams light into the eyes can improve the sight of ...

SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

awarding the drug breakthrough status. Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours ...

Remember when quantum computers seemed like science fiction? When satellites belonged only to governments? When flying cars existed only in The Jetsons? Artificial intelligence (AI), quantum ...

Liverpool forward Mohamed Salah will wait until later in the season to decide his future at Anfield, according to the latest reports. The Egypt international has been in good form once again this ...

The FDA has given breakthrough therapy designation to OMS721, a new treatment for the rare kidney disease immunoglobulin A (IgA) nephropathy. The news is a major boost for Seattle-based Omeros ...

Kennedy Jr., who is slated to hold a potentially big role in a new Trump administration, said Wednesday there are “entire departments” within the Food and Drug Administration (FDA) that ...

Justin Allgaier is the only driver to compete in all nine NASCAR Xfinity Series Playoffs, but he has never won a championship. Always a bridesmaid, never a bride. In those nine playoffs runs he ...

Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand for non-essential surgical procedures, especially among older patients.